Subjects | 176 (100%) |
Age years | |
Mean (range) | 62 (31–87) |
<50 | 28 (15.9%) |
50–59 | 48 (27.3%) |
60–69 | 55 (31.2%) |
≥70 | 45 (25.6%) |
Sex | |
Male | 89 (50.6%) |
Female | 87 (49.4%) |
Lymph node samples | |
Mediastinal | 120 (68.2%) |
Hilar | 23 (13.1%) |
Both | 33 (18.7%) |
EBUS-TBNA diagnosis | |
Non-neoplastic definitive diagnosis | 60 (34.1%) |
Metastasis from previous malignancy | 103 (58.5%) |
Different malignancy | 8 (4.6%) |
False negative | 5 (2.8%) |
Primary cancer | |
Breast | 50 (28.4%) |
Lung | 46 (26.1%) |
Head and neck | 16 (9.1%) |
Genitourinary | 21 (11.9%) |
Female genital tract | 10 (5.7%) |
Gastrointestinal | 9 (5.1%) |
Lymphoproliferative | 8 (4.6%) |
Multiple tumour sites | 12 (6.8%) |
Other | 4 (2.3%) |